Compare AVDL & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVDL | AVAH |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1996 | 2021 |
| Metric | AVDL | AVAH |
|---|---|---|
| Price | $21.69 | $7.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $19.14 | $10.56 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 03-02-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | $248,517,000.00 | ★ $2,290,591,000.00 |
| Revenue This Year | $65.47 | $21.81 |
| Revenue Next Year | $30.88 | $5.96 |
| P/E Ratio | ★ N/A | $20.95 |
| Revenue Growth | ★ 79.88 | 15.48 |
| 52 Week Low | $6.38 | $3.67 |
| 52 Week High | $23.57 | $10.32 |
| Indicator | AVDL | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 38.60 |
| Support Level | $21.52 | $7.68 |
| Resistance Level | $21.69 | $8.63 |
| Average True Range (ATR) | 0.06 | 0.38 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 66.67 | 10.98 |
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.